A Phase 1 Study of PTC596 in Patients With Advanced Solid Tumours
This is a Phase 1, open-label, first-in-human, safety and pharmacokinetic study of PTC596 in
patients with advanced cancer.
View this trial on ClinicalTrials.gov
Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.
These resources are provided in partnership with the
Canadian Cancer Society